1-substituted apomorphines as potent dopamine agonists.

Abstract

A novel set of 1-substituted apomorphines as dopaminergic agonists were synthesized according to our new strategy employing the acid-catalyzed rearrangement of diversely functionalized 5β-substituted-6-demethoxythebaines. The activities of new compounds for dopamine receptors subtypes were evaluated using HEK293 based stable cell lines expressing D1, D2L or D3 receptor subtypes. All studied compounds had affinities in nanomolar range for D2L and D3 receptors and the change of the nature of substituent in position 1 had only moderate effect. D1 receptors were sensitive to the introduction of the 4-OH-benzyl function resulting in an increased affinity. The small hydrophilic group (hydroxymethyl) highly reduced the agonist affinity and potency thereby increasing subtype selectivity. This strategy for selective modulation of affinities and potencies of 1-substituted apomorphines gives essential hints for future design of subtype selective dopaminergic ligands.

DOI: 10.1016/j.bmc.2013.05.014

Cite this paper

@article{ReinartOkugbeni20131substitutedAA, title={1-substituted apomorphines as potent dopamine agonists.}, author={Reet Reinart-Okugbeni and Argo Vonk and Ain Uustare and Zsuzsanna Gyulai and Attila Sipos and Ago Rinken}, journal={Bioorganic & medicinal chemistry}, year={2013}, volume={21 14}, pages={4143-50} }